# Laurent Arnould

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laurent-arnould/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,203 |
| Field | Breast Cancer Treatment Studies |
| h-index | 62 |
| i10-index | 167 |
| Last Known Institution | Siemens (Germany) |
| OpenAlex ID | https://openalex.org/A5071480204 |
| ORCID iD | https://orcid.org/0000-0001-6133-1362 |
| Works | 529 |

## Researcher papers

- [Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy](https://scholariq.org/papers/cancer-cell-autonomous-contribution-of-type-i-interferon-signaling-to-the/)
- [The landscape of viral associations in human cancers](https://scholariq.org/papers/the-landscape-of-viral-associations-in-human-cancers/)
- [Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial](https://scholariq.org/papers/switch-to-fulvestrant-and-palbociclib-versus-no-switch-in-advanced-breast-cancer/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Uterine Myomas and Treatments](https://scholariq.org/topics/uterine-myomas-and-treatments-2/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [Siemens (Germany)](https://scholariq.org/institutions/siemens-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.